| Date | Form | Description | Docs | XBRL | Pages |
| 09/02/14 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 08/27/14 | 8-K | Current report filing |
|
5 | |
| 08/14/14 | 8-K | Current report filing |
|
3 | |
| 07/17/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/17/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/17/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/17/14 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/15/14 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
43 | |
| 07/15/14 | 8-K | Current report filing |
|
54 | |
| 07/14/14 | 8-K | Current report filing |
|
5 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...